These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 39200142)

  • 1. Mesenchymal Stem Cells in Myelodysplastic Syndromes and Leukaemia.
    Eroz I; Kakkar PK; Lazar RA; El-Jawhari J
    Biomedicines; 2024 Jul; 12(8):. PubMed ID: 39200142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes.
    Xing T; Lyu ZS; Duan CW; Zhao HY; Tang SQ; Wen Q; Zhang YY; Lv M; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
    J Transl Med; 2022 Mar; 20(1):144. PubMed ID: 35351133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
    Wu L; Amarachintha S; Xu J; Oley F; Du W
    Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
    Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
    Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow niche in the myelodysplastic syndromes.
    Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
    Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
    Xu R; Huang X; Li C; Deng C; Li M; Wu P; Geng S; Lai P; Lu Z; Weng J; Du X
    Br J Haematol; 2021 Jun; 193(5):928-940. PubMed ID: 33959953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
    Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
    Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
    Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cell senescence in haematological malignancies.
    Plakhova N; Panagopoulos V; Vandyke K; Zannettino ACW; Mrozik KM
    Cancer Metastasis Rev; 2023 Mar; 42(1):277-296. PubMed ID: 36622509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAK Deficiency in Bone Marrow Stromal Cells Alters Their Homeostasis and Drives Abnormal Proliferation and Differentiation of Haematopoietic Stem Cells.
    Wu Y; Campos L; Daguenet E; He Z; Picot T; Tavernier-Tardy E; Soglu G; Guyotat D; Aanei CM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32155953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
    Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zheng L; Zhang L; Guo Y; Xu X; Liu Z; Yan Z; Fu R
    Front Immunol; 2022; 13():1078421. PubMed ID: 36569863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes.
    Bandara WMMS; Rathnayake AJIS; Neththikumara NF; Goonasekera HWW; Dissanayake VHW
    Blood Cells Mol Dis; 2021 May; 88():102535. PubMed ID: 33461003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche.
    Gerber-Ferder Y; Cosgrove J; Duperray-Susini A; Missolo-Koussou Y; Dubois M; Stepaniuk K; Pereira-Abrantes M; Sedlik C; Lameiras S; Baulande S; Bendriss-Vermare N; Guermonprez P; Passaro D; Perié L; Piaggio E; Helft J
    Nat Cell Biol; 2023 Dec; 25(12):1736-1745. PubMed ID: 38036749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk.
    Fattizzo B; Giannotta JA; Barcellini W
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
    Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS
    Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells.
    van Spronsen MF; Van Gassen S; Duetz C; Westers TM; Saeys Y; van de Loosdrecht AA
    Leukemia; 2024 Jun; 38(6):1365-1377. PubMed ID: 38459168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.